Adult-onset dermatomyositis complicated by calcinosis cutis

Wounds

Volumn 16, Issue 12, 2004, Pages 364-370

  Dasgeb, Bahar ^a   Phillips, Tania J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM ION; CHLORAMBUCIL; CORTICOSTEROID; CREATINE KINASE; CYCLOPHOSPHAMIDE; DAPSONE; DILTIAZEM; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; MEPREDNISONE; METHOTREXATE; PREDNISONE; PROBENECID; RETINOID; THALIDOMIDE; WARFARIN;

ANAMNESIS; ARTICLE; CALCIFICATION; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DOSE RESPONSE; HIP; HUMAN; INTERSTITIAL LUNG DISEASE; PHOTOSENSITIVITY; PLASMAPHERESIS; RASH; SEROLOGY; SKIN AUTOGRAFT; SKIN CALCIFICATION; SKIN ULCER;

EID: 12444321975     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Jorizzo JL. Dermatomyositis, Rheumatologic Diseases, Dermatology in General Medicine. New York NY: McGraw-Hill, 1987:615-22.
2. Burns DA, Breathnach SM, Cox N, Griffiths CE. Rook's Textbook of Dermatology. Oxford, UK: Blackwell Science, 1998.
3. Garcia-Patos V, Bartralot R, Ordi J, et al. Childhood sclerodermatomyositis: Report of a case with the anti-PM/Scl antibody and mechanic's hands. Br J Dermatol 1996;135(4):613-6.
4. Sontheimer RD. Dermatomyositis. In: Freedburg IM, Eisen AZ, Wolff K, et al. (eds). Fitzpatrick's Dermatology in General Medicine, Fifth Edition. New York, NY: McGraw-Hill, 1999:2009-22.
5. Mukamel M, Horev G, Mimouni M. New insight into calcinosis of juvenile dermatomyositis: A study of composition and treatment. J Pediatrics 2001;138(5):736-66.
6. Murphy E, Freaney R, Bresnihan B, McKenna M, FitzGerald O. Increased bone resorption and failure to respond to antiresorptive therapy in progressive dystrophic calcification. Calcified Tissue International 2003;73(5):433-40.
7. Weinel S, Callen J. Calcinosis cutis complicating adult-onset dermatomyositis. Arch Dermatol 2004;140(3):365-6.
8. Callen J. Dermatomyositis. In: Dermatologic Signs in Internal Diseases. Philadelphia, PA: WB Saunders, 1998:13-20.
9. Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 2002;47(4):505-11.
10. Matsuka Y, Miyajima S, Okada N. A case of calcinosis universalis successfully treated with low-dose warfarin. J Dermatol 1998;25(11):716-20.
11. Vienen C, Patel S, Bruckner FE. Regression of calcinosis associated with adult dermatomyositis following diltiazem therapy. Rheumatology 2000;39:333-4.
12. Mukamel M, Horev G, Mimouni M. New insight into calcinosis of juvenile dermatomyositis: A study of composition and treatment. J Pediatrics 2001;138(5):763-6.
13. Harel L, Harel G, Korenreich L, Straussburg R, Amir J. Treatment of calcinosis in juvenile dermatomyositis with probenecid: The role of phosphorus metabolism in the development of calcification. J Rheumatol 2001;28(5):1129-32.
14. Elhasid R, Rowe JM, Berkowitz D, Ben-Arush M, Brik R. Disappearance of diffuse calcinosis following autologous stem cell transplantation in a child with autoimmune disease. Bone Marrow Transplant 2004;33(12):1257-9.